Cencora Financial Results
Cencora reported fiscal year 2026 revenue of $337.4 billion, up 5.0% year-over-year, and adjusted diluted EPS of $17.97. The company introduced a new operating model and reportable segments following its acquisition of OneOncology and provided fiscal 2027 adjusted EPS guidance of $19.40 to $19.75.
- Term
- FY2026
“Fiscal 2026 was a pivotal year for Cencora, as we expanded our MSO platform through the acquisition of OneOncology, sharpened the focus of our portfolio and delivered record results.”
Robert P. Mauch, President and Chief Executive Officer of Cencora
“As we enter fiscal 2027, our new operating model is designed to strengthen our execution and provide visibility to our progress.”
Robert P. Mauch, President and Chief Executive Officer of Cencora